Apex Therapeutics Presented Company Overview at This Years BIO International Convention in Philadelphia, PA

Indianapolis, IN (PRWEB) July 01, 2015 Apex Therapeutics announced today that company CEO, David Broecker provided a company update at the 2015 BIO International Convention in Philadelphia, PA. The presentation took place on Tuesday, June 16 and provided an update on the achievement of corporate milestones and outlined the plans for the ...

T3D Therapeutics, Inc. Awarded SBIR Phase 2 Grant From The National Institute On Aging For Alzheimer’s Disease Drug Testing

Research Triangle Park, NC (PRWEB) March 24, 2015 T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer’s disease therapies announced today that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company a Small Business Innovation Research (SBIR) Phase 2 grant for the clinical development of ...

Medullary Thyroid Cancer Therapeutics Clinical Trials Market Review H1 2015 Available at RnRMarketResearch.com

Medullary Thyroid Cancer Therapeutics Clinical Trials Market Review H1 2015 Available at RnRMarketResearch.com
Dallas, Texas (PRWEB) April 30, 2015 The report “Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015” provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. Complete report on H1 2015 Clinical Trials review of “Medullary Thyroid Cancer” addiction with 44 market data tables and 109 figures, spread across 65 ...

World Peptide Therapeutics Marketplace Discussed by PNS Pharma in New Research Study Published at MarketPublishers.com

World Peptide Therapeutics Marketplace Discussed by PNS Pharma in New Research Study Published at MarketPublishers.com
London, UK (PRWEB) February 24, 2015 The use of peptides for treating a number of disease indications have been proved by researchers and some of them are currently available in the market. Peptide based therapeutics are frequently used in drug development programmes to offer greater pharmacological effects and help alleviate the medical symptoms and ...

Allegheny Health Network Recruits World-Renowned Diabetes Researcher, Team of 19 to Lead New Institute of Cellular Therapeutics

Allegheny Health Network Recruits World-Renowned Diabetes Researcher, Team of 19 to Lead New Institute of Cellular Therapeutics
Pittsburgh, PA (PRWEB) June 11, 2014 Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a newly established Institute of Cellular Therapeutics based at Allegheny General Hospital (AGH). Joining Dr. Trucco in the transition of his program ...

Therabron Therapeutics, Inc. Secures Up to $11M in Series B Financing

Therabron Therapeutics, Inc. Secures Up to $11M in Series B Financing
Rockville, Maryland (PRWEB) December 17, 2014 Therabron Therapeutics, Inc., a privately held clinical-stage biotechnology company, today announced that it has secured an investment of up to $ 11.1M in multiple tranches of a Series B Financing from Brace Pharmaceuticals LLC, Zell Biotech Two LLC, and three other investors. The new funding will help Therabron Therapeutics ...

Immunomic Therapeutics, Inc. Makes Significant Headway in Regulatory Interactions in Japan

Immunomic Therapeutics, Inc. Makes Significant Headway in Regulatory Interactions in Japan
Hershey, PA (PRWEB) December 05, 2014 Representatives of Immunomic Therapeutics, Inc. (ITI) met in Tokyo recently with the Japanese Pharmaceutical Medical Device Agency (PMDA) for a formal discussion regarding its proposed clinical study of JRC2*-LAMP-vax in Japan. The protocol plans for a clinical trial of its bivalent non-viral DNA vaccine for patients with Japanese Red ...

Catalent and Valerion Therapeutics Collaborate to Bring New Treatments for Orphan Genetic Disorders to Market

Somerset, N.J. (PRWEB) December 02, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to collaborate with Valerion Therapeutics, LLC, an emerging science-driven company, focused on the development of bio-therapeutics for orphan genetic diseases, to develop Valerion’s ...

Global Market for miRNA Research Tools, Diagnostics and Therapeutics to Reach $1 Billion by 2019; Expeditious Growth in miRNA Research Fueling Development

Global Market for miRNA Research Tools, Diagnostics and Therapeutics to Reach $1 Billion by 2019; Expeditious Growth in miRNA Research Fueling Development
Wellesley, Mass. (PRWEB) November 13, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets, the global market for microRNA (miRNA) research tools, services, diagnostics and drug discovery is expected to reach $ 1 billion by 2019, at a compound annual growth rate (CAGR) of 12.6% for the ...